See also the product is king.docVIP

 PAGE \* MERGEFORMAT 8 See also the ‘product is king’ In recent days, and some medical circles chatting with a friend, we have lamented the industry consolidation and the impact of change is indeed great. Around struggling companies, sales are down is normal, tight clothing companies cut food operation is to do, take the initiative to actively seek change is necessary to adapt to the future development is dazed. We are looking for major health reform policy, market opportunities, while one after another will operate points to a direction: product. Agency co-operation in particular, rely on pharmaceutical commercial enterprises, the product demand is an unprecedented urgency. Are concerned about through various channels, there are no new varieties available, as well as Which enterprises are not being taken seriously, but the market is not promising varieties. Moreover, two good friends, one of the fancy new formulation of a three drugs, imitation of a big brand new models, and has good details about readiness to cooperate. Inadvertently disclosed this information to their friends, his friend is also positive about this species, and manufacturers always the case flew into contact, and 2 million advance deposit and the first payment, appropriation, this species will appear. After hearing this story I can not help but sigh: Product is king era has returned. First, the development of the pharmaceutical industry context China’s pharmaceutical market, from the traditional planned economy era coming, due to economic conditions, scientific research and the market system constraints, from the 20th century, 80 years pharmaceutical market since the opening operations, markets plunged into an unprecedented era of warm. Many individuals and manufacturers have to rely on a certain species can be very easy to make a bowl full of pots full. In respect of the planned economy era and personal representatives of the commercial allocation of unprecedented prosperity, and some a